BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 19861128)

  • 1. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.
    Davis GL; Alter MJ; El-Serag H; Poynard T; Jennings LW
    Gastroenterology; 2010 Feb; 138(2):513-21, 521.e1-6. PubMed ID: 19861128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projecting future complications of chronic hepatitis C in the United States.
    Davis GL; Albright JE; Cook SF; Rosenberg DM
    Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan.
    Yu ML; Chuang WL; Chen SC; Dai CY; Hou C; Wang JH; Lu SN; Huang JF; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY
    J Med Virol; 2001 Sep; 65(1):58-65. PubMed ID: 11505444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral lichen planus, hepatitis C virus, and HIV: no association in a cohort study from an area of high hepatitis C virus endemicity.
    Campisi G; Di Fede O; Craxi A; Di Stefano R; Margiotta V
    J Am Acad Dermatol; 2004 Sep; 51(3):364-70. PubMed ID: 15337978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival.
    Staples CT; Rimland D; Dudas D
    Clin Infect Dis; 1999 Jul; 29(1):150-4. PubMed ID: 10433578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.
    Alter MJ; Kruszon-Moran D; Nainan OV; McQuillan GM; Gao F; Moyer LA; Kaslow RA; Margolis HS
    N Engl J Med; 1999 Aug; 341(8):556-62. PubMed ID: 10451460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited success of HCV antiviral therapy in United States veterans.
    Cawthorne CH; Rudat KR; Burton MS; Brown KE; Luxon BA; Janney CG; Fimmel CJ
    Am J Gastroenterol; 2002 Jan; 97(1):149-55. PubMed ID: 11808940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma and hepatitis C in the United States.
    El-Serag HB
    Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.
    Armstrong GL; Alter MJ; McQuillan GM; Margolis HS
    Hepatology; 2000 Mar; 31(3):777-82. PubMed ID: 10706572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
    J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission.
    Di Stefano R; Stroffolini T; Ferraro D; Usticano A; Valenza LM; Montalbano L; Pomara G; Craxì A
    J Med Virol; 2002 Jul; 67(3):339-44. PubMed ID: 12116024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.
    Wang CC; Krantz E; Klarquist J; Krows M; McBride L; Scott EP; Shaw-Stiffel T; Weston SJ; Thiede H; Wald A; Rosen HR
    J Infect Dis; 2007 Nov; 196(10):1474-82. PubMed ID: 18008226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group.
    Kaur S; Rybicki L; Bacon BR; Gollan JL; Rustgi VK; Carey WD
    Hepatology; 1996 Nov; 24(5):979-86. PubMed ID: 8903363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.